Valuation : DiaSorin S.p.A.

Market Cap 3.81B 4.44B 3.57B 3.27B 6.16B 424B 6.17B 42.25B 16.52B 214B 16.67B 16.31B 707B P/E 2026 *
22.3x
P/E 2027 * 19.7x
Enterprise Value 4.52B 5.26B 4.23B 3.87B 7.3B 503B 7.32B 50.09B 19.58B 253B 19.76B 19.33B 838B EV / Sales 2026 *
3.66x
EV / Sales 2027 * 3.32x
Free-Float
37.17%
Yield 2026 *
1.69%
Yield 2027 * 1.77%
1 day+1.77%
1 week+3.05%
Current month+7.15%
1 month+14.79%
3 months+17.56%
6 months+8.15%
Current year+12.21%
1 week 74.7
Extreme 74.7
77
1 month 68.74
Extreme 68.74
77
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
86.94
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
1/28/26 A Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 A Buy

Director

700 0.0013%
1/8/26 A Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+1.77%+3.05%-9.60%-17.22% 4.44B
-1.40%+0.38%+165.39%+340.11% 22.61B
+1.62%+1.21%-36.55%-21.07% 10.35B
+0.92%+1.53%+362.55%+35.41% 8.45B
-1.64%+7.32%-30.98% - 7.45B
-0.35%+0.23%+76.76%+51.38% 6.56B
-0.12%-3.82%-14.67%-10.78% 5.94B
-2.48%-11.72%+56.86%+98.49% 4.33B
+0.26%-0.55%-19.52%-24.57% 2.85B
-3.49%+6.59% - - 1.35B
Average -0.48%+1.36%+61.14%+56.47% 7.43B
Weighted average by Cap. -0.39%+0.87%+92.60%+127.05%

Financials

2026 *2027 *
Net sales 1.23B 1.44B 1.16B 1.06B 1.99B 137B 2B 13.69B 5.35B 69.22B 5.4B 5.28B 229B 1.31B 1.53B 1.23B 1.12B 2.12B 146B 2.12B 14.52B 5.68B 73.44B 5.73B 5.6B 243B
Net income 181M 210M 169M 155M 292M 20.09B 292M 2B 782M 10.12B 790M 773M 33.51B 205M 239M 192M 176M 332M 22.86B 333M 2.28B 891M 11.52B 899M 879M 38.14B
Net Debt 707M 823M 661M 606M 1.14B 78.61B 1.14B 7.83B 3.06B 39.62B 3.09B 3.02B 131B 541M 631M 507M 464M 874M 60.24B 877M 6B 2.35B 30.36B 2.37B 2.32B 100B
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
27/08/26 €77.00 +1.77% 183,344
26/08/26 €75.66 -0.39% 116,144
25/08/26 €75.96 +0.64% 64,276
24/08/26 €75.48 +0.45% 125,240
21/08/26 €75.14 +0.56% 93,397
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
77.00EUR
Average target price
71.66EUR
Spread / Average Target
-6.93%

Quarterly revenue - Rate of surprise